CGI Pharmaceuticals, Inc. Email Format
Pharmaceutical ManufacturingConnecticut, United States2-10 Employees
CGI Pharmaceuticals, Inc. was a small, venture-backed entity built around kinase drug discovery and originated as a Yale University spin-out in 2000. Its research laboratories were located in Branford, Connecticut, contributing to the pharmaceutical development ecosystem. In 2010, CGI was acquired by Gilead Sciences, and its Branford facilities now operate as part of Gilead's Connecticut operations. Positioned in the pharmaceutical manufacturing industry, CGI's work centered on identifying kinase inhibitors as part of early-stage drug discovery programs. The company served the pharmaceutical sector looking to advance therapeutic candidates, though specific customer relationships are not detailed in the available information. The location is Branford, Connecticut, where its laboratories were based, illustrating a localized footprint within the United States.